
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes

Wednesday Dec 01, 2021
Navigating Virtual Midyear 2021: Expert Advice and Must-Watch Sessions
Wednesday Dec 01, 2021
Wednesday Dec 01, 2021
Join Brittany Tschaen as she sits down with Joe Marchiano and Rena Gosser who will share their lessons learned and best practices for attending the virtual Midyear Clinical Meeting including navigating networking opportunities, attending live sessions and making the most of the virtual platform. Later in the episode, Brittany sits down with three program chairs from the 2021 Midyear Clinical Meeting who will provide an exclusive preview into their presentations prior to the start of the Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday Nov 30, 2021
A Front Seat View to a Pharmacy Legend
Tuesday Nov 30, 2021
Tuesday Nov 30, 2021
In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with William Zellmer to discuss Dr. Oddis’s career and his contributions to the pharmacy profession.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Nov 29, 2021
Monday Nov 29, 2021
In this episode of the Life & Legacy of Joseph A. Oddis, host Daniel Cobaugh sits down with Paul Abramowitz, ASHP CEO, to talk about his many fond memories of Dr. Oddis. They discuss how Dr. Oddis’s leadership and vision laid the foundation for ASHP to evolve into the successful organization it is today.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Sunday Nov 28, 2021
Sunday Nov 28, 2021
Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Sunday Nov 28, 2021
Sunday Nov 28, 2021
Tune in to this podcast episode on acute kidney biomarker testing and how pharmacists may apply acute kidney injury biomarkers in their clinical practice. From the 2020 Midyear Clinical Meeting, content matter experts explore the use of NGAL and TIMP-2*IGFBP-7 in clinical practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Saturday Nov 27, 2021
Saturday Nov 27, 2021
In this debate style presentation from the 2020 Midyear Clinical Meeting, our content matter experts examine the pros and cons of DOACs and Warfarin in patients with End Stage Renal Disease through a review of the literature. Who will you convince you? Listen in and decide!
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Saturday Nov 27, 2021
Vancomycin Therapeutic Drug Monitoring — The Times They Are a Changin’
Saturday Nov 27, 2021
Saturday Nov 27, 2021
Preview this BCCCP and BCPS recertification offering from the Midyear Clinical Meeting. This episode will review the current paradigm shift from trough concentration-guided vancomycin dosing and therapeutic drug monitoring (TDM) to area under the concentration-time curve (AUC)-guided vancomycin dosing and TDM and will prepare pharmacists for this paradigm shift and provide real-world examples of AUC monitoring implementation by multiple methods. Like what you hear and want to hear the rest and apply what you learn for recertification credit? Purchase the recertification product here.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday Nov 23, 2021
Exploring Residency Programs: A Focus on Pharmacogenomics
Tuesday Nov 23, 2021
Tuesday Nov 23, 2021
Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Nov 22, 2021
Monday Nov 22, 2021
In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Nov 19, 2021
Ambulatory Care Residency Training: Identifying the Best Fit
Friday Nov 19, 2021
Friday Nov 19, 2021
Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
